TickerStat.comwe like data

Cero Therapeutics Holdings, Inc. (CERO)

Price$0.00975Cached quote
CEROOTC
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20252024202320222021
Revenue$0—$0$0$0
Research & development$10.4M$6.3M$5.3M$9.8M$9.1M
Operating expenses$19.3M$15.3M$7.7M$2.9M$332,030
Operating income−$19.3M−$15.3M−$7.7M−$2.9M−$11.6M
EBITDA−$18.2M—−$6.6M−$10.9M−$10.9M
Net income−$19.9M−$7.7M−$7.3M−$667,736−$315,547
Basic EPSper basic share-$22.58-$18.15-$1,248.64-$2,610.71-$2,345.98
Diluted EPSper diluted share-$22.58-$18.15-$1,248.64-$2,610.71-$2,345.98
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)8$1.16M disclosed value
8 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 13, 2024Form 4YK Bioventures Opportunities GP I, LLC +3TenPercentOwnerSellCommon Stock · indirect3.00M$0.06$179.9K13.01M
Dec 12, 2024Form 4YK Bioventures Opportunities GP I, LLC +3TenPercentOwnerSellCommon Stock · indirect1.61M$0.07$113.0K16.00M
Dec 11, 2024Form 4YK Bioventures Opportunities GP I, LLC +3TenPercentOwnerSellCommon Stock · indirect1.34M$0.08$107.5K17.62M
Dec 10, 2024Form 4Kossar Mitchell William +3TenPercentOwnerSellCommon Stock · indirect1.57M$0.09$141.4K18.96M
Dec 9, 2024Form 4Kossar Mitchell William +3TenPercentOwnerSellCommon Stock · indirect850.5K$0.11$93.6K20.53M
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about CERO yet. Start the conversation.

Write the first post